Arvinas (ARVN) Gains from Sales and Divestitures (2018 - 2021)
Arvinas (ARVN) recorded quarterly Gains from Sales and Divestitures of $44355.0 in Q3 2021, up 9.94% quarter-over-quarter from $40344.0 in Q2 2021, and down 2.19% on a YoY basis from $45346.0 in Q3 2020.
Arvinas (ARVN) Gains from Sales and Divestitures (2018 - 2021) Analysis & Trends
Arvinas' Gains from Sales and Divestitures history runs 4 years deep, the most recent figure standing at $44355.0 for Q3 2021.
- In Q3 2021, Gains from Sales and Divestitures fell 2.19% year-over-year to $44355.0; the TTM figure through Sep 2021 stood at $44355.0 (down 2.19% YoY), while the FY2020 annual figure was $325818.0, down 31.51% from the prior year.
- Gains from Sales and Divestitures was $44355.0 for Q3 2021 at Arvinas, up from $40344.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $475730.0 in Q4 2019 to a low of $40344.0 in Q1 2021.
- Historically, Gains from Sales and Divestitures has averaged $168806.4 across 4 years, with a median of $110530.0 in 2019.
- The sharpest annual moves came in 2019 and 2020: Gains from Sales and Divestitures soared 229.72% in 2019, then plunged 88.18% in 2020.
- A 4-year view of Gains from Sales and Divestitures shows it stood at $144283.0 in 2018, then jumped by 229.72% to $475730.0 in 2019, then tumbled by 31.51% to $325818.0 in 2020, then sank by 86.39% to $44355.0 in 2021.
- The last three Gains from Sales and Divestitures figures came in at $44355.0 (Q3 2021), $40344.0 (Q2 2021), and $40344.0 (Q1 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 44,355.00 |
| Sep 30, 2021 | 44,355.00 |
| Jun 30, 2021 | 40,344.00 |
| Jun 30, 2021 | 40,344.00 |
| Mar 31, 2021 | 40,344.00 |
| Mar 31, 2021 | 40,344.00 |
| Dec 31, 2020 | 325,818.00 |
| Dec 31, 2020 | 325,818.00 |
| Sep 30, 2020 | 45,346.00 |
| Sep 30, 2020 | 45,346.00 |
| Jun 30, 2020 | 41,336.00 |
| Jun 30, 2020 | 41,336.00 |
| Mar 31, 2020 | 87,336.00 |
| Mar 31, 2020 | 87,336.00 |
| Dec 31, 2019 | 475,730.00 |
| Dec 31, 2019 | 475,730.00 |
| Sep 30, 2019 | 383,695.00 |
| Sep 30, 2019 | 383,695.00 |
| Jun 30, 2019 | 263,366.00 |
| Jun 30, 2019 | 263,366.00 |